Brief: Ultimovacs Announces Agreement To Combine Its Business With Zelluna Immunotherapy And Intention To Launch Fully Committed Private Placement
17/12/2024 16:55
Dec 17 (Reuters) - Ultimovacs ASA ULTI.OL :
* ULTIMOVACS ANNOUNCES AGREEMENT TO COMBINE ITS BUSINESS
WITH
ZELLUNA IMMUNOTHERAPY AND INTENTION TO LAUNCH FULLY COMMITTED
PRIVATE PLACEMENT
* ULTIMOVACS ASA - RECEIVES PRE-COMMITMENTS FOR NOK 51.7
MILLION
PRIVATE PLACEMENT
Source text: ID:nGNE53q5k
Further company coverage: ULTI.OL
((reuters.briefs@thomsonreuters.com;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant